Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis.
about
A review of potential harmful interactions between anticoagulant/antiplatelet agents and Chinese herbal medicinesEvidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesThe Effect of Ginger (Zingiber officinale) on Platelet Aggregation: A Systematic Literature ReviewDirect and indirect risk associated with the use of dietary supplements among persons with dementia in a Norwegian memory clinicSafety relevant knowledge of orally anticoagulated patients without self-monitoring: a baseline survey in primary care.Prescribing warfarin appropriately to meet patient safety goals.Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review.Commonly Used Dietary Supplements on Coagulation Function during SurgeryAssociation between CHADS₂risk factors and anticoagulation-related bleeding: a systematic literature review.Interaction between warfarin and Chinese herbal medicinesReducing drug-herb interaction risk with a computerized reminder system.Medical reconciliation of dietary supplements: don't ask, don't tell.Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study.Effects of naturopathic medicines on Multiplate and ROTEM: a prospective experimental pilot study in healthy volunteers.Genetic testing for warfarin therapy initiation.Updates on the clinical evidenced herb-warfarin interactions.Patient factors that influence warfarin dose response.Are the risk factors listed in warfarin prescribing information associated with anticoagulation-related bleeding? A systematic literature review.Effect of acetaminophen on international normalized ratio in patients receiving warfarin therapy.Warfarin and acetaminophen interaction: a summary of the evidence and biologic plausibility.A commonly used Chinese herbal formula, Shu-Jing-Hwo-Shiee-Tang, potentiates anticoagulant activity of warfarin in a rabbit model.Pro and contra duration restriction of treatment with willow bark extract.Prevalence of use and the risk of adverse effects associated with complementary and alternative medicine in a cohort of patients receiving warfarin.Bridging cross-cultural gaps: monitoring herbal use during chemotherapy in patients referred to integrative medicine consultation in Israel.Probable Interaction Between Warfarin and Banana Flakes Supplement.Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.Distribution characteristics and factors influencing oral warfarin adherence in patients after heart valve replacement
P2860
Q21090750-7A287A7B-95D2-4EC0-A577-C63619A061D6Q24632951-02A548D2-3220-4AC7-AFEF-917F4090F7A1Q28550429-03E88463-451A-447C-9617-A526AC402B86Q33668027-410CD66A-27AF-494E-9BD6-D2C82B326336Q33712459-2588286F-1C0C-4719-BD4C-DB9B7EFD52A7Q33932089-D7D27BF4-F1C2-4E15-96BC-2D7AF203135FQ34306204-DEFCD4BD-BE7B-4E99-A662-24F7A740746CQ34517159-54F7E52A-3812-44E6-A472-5BB2B15A51FFQ35016262-05A0035B-6569-44A8-9AA9-399133508DD6Q35076285-54CF46C0-C632-441F-A1B7-A71E152A3A1FQ35111490-467D2526-6F1A-44EB-ADAE-75320094D5B4Q35498322-3D95CF74-4227-41A2-AD54-48395350C388Q35553851-26052E56-22DC-4011-AFCD-06FC4F810C46Q35926496-39EDF2FD-4B37-4351-B874-AAE7D9882001Q37235860-204BC945-A567-47B5-B19A-B10A2C6C35E4Q37686931-38B4856D-DBCB-44FC-B404-74887D7B5ED7Q37867275-A01140CB-8328-4C46-92C5-95788BF549E8Q37890023-719DBCD9-7AA5-4657-A69E-43D36489B60FQ37933369-1DAEB02F-AB9D-43ED-98E0-8817CA2FAA56Q41107009-3309F2BC-F889-49E5-B092-27357E4024EFQ44444244-1B32E680-85CB-48AE-839D-0142A18AF70BQ44958348-18CA2370-5F53-4C28-9E6A-5057397008F2Q46032921-C50F0E56-61A7-47D7-9778-F41063A14054Q46741772-9B4DF68F-1931-4789-AC12-DFF71026844AQ49014123-5FD61244-45F6-441B-8EC5-3AB736E4488FQ51439071-1BCEE8EA-A442-46DE-B911-9B8E6DDA4D20Q58767817-447CB3CB-F299-4D15-AB81-A28B50A11946
P2860
Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Risk of warfarin-related bleed ...... cine: a longitudinal analysis.
@ast
Risk of warfarin-related bleed ...... cine: a longitudinal analysis.
@en
Risk of warfarin-related bleed ...... cine: a longitudinal analysis.
@nl
type
label
Risk of warfarin-related bleed ...... cine: a longitudinal analysis.
@ast
Risk of warfarin-related bleed ...... cine: a longitudinal analysis.
@en
Risk of warfarin-related bleed ...... cine: a longitudinal analysis.
@nl
prefLabel
Risk of warfarin-related bleed ...... cine: a longitudinal analysis.
@ast
Risk of warfarin-related bleed ...... cine: a longitudinal analysis.
@en
Risk of warfarin-related bleed ...... cine: a longitudinal analysis.
@nl
P2093
P356
P1433
P1476
Risk of warfarin-related bleed ...... cine: a longitudinal analysis.
@en
P2093
Andrew Ingaszewski
Charles Kerr
Kathryn Richardson
Larry Lynd
Stephen Shalansky
P304
P356
10.1592/PHCO.27.9.1237
P407
P577
2007-09-01T00:00:00Z